Interestingly, the T2D PRS was not associated with treatment response to metformin, thiazolidinediones, SGLT2 inhibitors or sulfonylureas (Extended Data Fig. 8a) either before or after Bonferroni correction. Here, SLC5A2 is linked to type 2 diabetes mellitus.